Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
In the video, Shelley, a 70-year-old diagnosed with acute myeloid leukemia after her chronic myelomonocytic leukemia progressed, shares her cancer journey and how participating in a clinical trial…
NEW YORK (Reuters Health) – Chemotherapy-induced delayed nausea remains a significant problem, despite the availability of second-generation antiemetics, researchers say. In a study they conducted, over half of…
NEW YORK (Reuters Health) – In advanced ovarian cancer, extensive lymph node dissection in a second-look operation does not improve survival, Italian researchers say. Their randomized trial addressed…
NEW YORK (Reuters Health) – Patients with esophageal cancer appear to have equally good survival after minimally invasive esophagectomy (MIE) or traditional open surgery, according to a new…
NEW YORK (Reuters Health) – In women with hormone-receptor-positive metastatic breast cancer, combining anastrozole and fulvestrant extends progression-free and overall survival, according to a paper released online today…
NEW YORK (Reuters Health) – Metallic stents used to relieve malignant ureteral obstruction may not perform any better than conventional polyurethane stents, according to a new study. “We…
NEW YORK (Reuters Health) – Adding gemtuzumab ozogamicin (GO) to induction chemotherapy improved survival in older patients with acute myeloid leukemia (AML), with no apparent additional toxicity, in…
How does the body store the toxins and xenoestrogens we ingest with our food? Robert Berger, PhD and Editor-in-Chief of Nutricula Magazine, discusses how these substances get stored in fat…
It’s highly debated whether patients undergoing radiation therapy for prostate cancer should also have their lymph nodes treated. Janna Andrews, MD, discusses the RTOG trials and their results, which…
With the continual advancement of technology in surgery, one would expect that robotic prostatectomy to be the gold standard of treatment for prostate cancer. However, Judd Moul, MD,…
Charles Jungreis, MD, Chairperson, Department of Radiology, Professor, Temple University School of Medicine, discusses stereotactic radiosurgery. References and Resources Cesaretti JA, Pennathur A, Rosenstein BS, Swanson SJ, Fernando…
